72 related articles for article (PubMed ID: 7700094)
1. [Lhermitte's sign as a complication of cisplatin treatment].
Martínez López E; Gallego Cullere J; Illarramendi Mañas JJ; Arias de la Vega F
Med Clin (Barc); 1995 Mar; 104(8):317-8. PubMed ID: 7700094
[No Abstract] [Full Text] [Related]
2. Cisplatin-related Lhermitte's sign.
Inbar M; Merimsky O; Wigler N; Chaitchik S
Anticancer Drugs; 1992 Aug; 3(4):375-7. PubMed ID: 1421433
[TBL] [Abstract][Full Text] [Related]
3. Cisplatinum neuropathy with Lhermitte's sign.
Kumar L; Kochupillai V; Kotwal PP
J Assoc Physicians India; 1991 Sep; 39(9):715-6. PubMed ID: 1667659
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin neuropathy with Lhermitte's sign.
Williams AC; Cullen MH; Haynes IG
J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1326. PubMed ID: 3794744
[No Abstract] [Full Text] [Related]
5. The development of Lhermitte's sign during cisplatin chemotherapy. Possible drug-induced toxicity causing spinal cord demyelination.
Walther PJ; Rossitch E; Bullard DE
Cancer; 1987 Nov; 60(9):2170-2. PubMed ID: 3440227
[TBL] [Abstract][Full Text] [Related]
6. On the significance of Lhermitte's sign in oncology.
Ventafridda V; Caraceni A; Martini C; Sbanotto A; De Conno F
J Neurooncol; 1991 Apr; 10(2):133-7. PubMed ID: 1895161
[TBL] [Abstract][Full Text] [Related]
7. Lhermitte's phenomenon and platinum, beware of latency.
O'Reilly A; Ryan S; MacEneaney P; O'Reilly SP; Cronin S; Power DG
Oncol Res Treat; 2014; 37(10):591-4. PubMed ID: 25342510
[TBL] [Abstract][Full Text] [Related]
8. Protracted Lhermitte's sign following head and neck irradiation.
Thornton AF; Zimberg SH; Greenberg HS; Sullivan MJ
Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1300-3. PubMed ID: 1747238
[TBL] [Abstract][Full Text] [Related]
9. [Cisplatin polyneuropathy].
Beghi E; Bogliun G; Crespi V; Delodovici ML; Landoni F
Riv Neurobiol; 1984; 30(2-3):431-7. PubMed ID: 6100526
[No Abstract] [Full Text] [Related]
10. [Lhermitte's sign after treatment with cisplatin].
Le Moing P; Bauduer F; Genot JY; Peny AM; Tanguy A
Presse Med; 1988 May; 17(17):875. PubMed ID: 2838838
[No Abstract] [Full Text] [Related]
11. [A rare complication of cisplatin: Lhermitte's sign].
de Gramont A; Krulik M; Gonzalez Canali G; Roullet E; Debray J
Presse Med; 1988 Jan; 17(3):123. PubMed ID: 2831529
[No Abstract] [Full Text] [Related]
12. Cisplatin neuropathy with Lhermitte's sign.
Dewar J; Lunt H; Abernethy DA; Dady P; Haas LF
J Neurol Neurosurg Psychiatry; 1986 Jan; 49(1):96-9. PubMed ID: 3007675
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
14. Lhermitte's sign in thoracic spinal tumour. Personal observation.
Broager B
Acta Neurochir (Wien); 1978; 41(1-3):127-35. PubMed ID: 665325
[TBL] [Abstract][Full Text] [Related]
15. Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature.
Kanchandani R; Howe JG
J Neurol Neurosurg Psychiatry; 1982 Apr; 45(4):308-12. PubMed ID: 7077340
[TBL] [Abstract][Full Text] [Related]
16. [Lhermitte's sign in pernicious anemia].
Gastón Morata JL; Urbano Jiménez F; Ampuero Ampuero J; Morata García F
Rev Clin Esp; 1983 May; 169(4):263-4. PubMed ID: 6622770
[No Abstract] [Full Text] [Related]
17. Lhermitte's sign.
Pearce JM
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):846. PubMed ID: 8021675
[No Abstract] [Full Text] [Related]
18. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
Greco FA; Hainsworth JD
Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site.
Park YH; Ryoo BY; Choi SJ; Yang SH; Kim HT
Jpn J Clin Oncol; 2004 Nov; 34(11):681-5. PubMed ID: 15613558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
